Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 2,653-2,664 of 6,115
Drug study icon
CompletedNCT00578669

Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In Providence
Why is this study shown?

This study is directly about Depression.

Depression, AddictionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Depression, Addiction
Drug study icon
CompletedNCT04814355

The Effect of Celecoxib on Neuroinflammation in MDD

This summary needs review. Please check the official study record and contact the research team for details.

In Stony Brook
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Stony Brook University
Condition
Depression
Drug study icon
CompletedNCT02646449

Treatment of Young Adults With Comorbid AUD/MDD: A Medication study

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
Why is this study shown?

This study is directly about Depression.

Depression, AddictionDrugFrom 18 Years to 30 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Depression, Addiction
Drug study icon
CompletedEUCTR 2006-000105-38

A definitive multi-centre pragmatic randomised controlled double-blind trial of the clinical and cost effectiveness of mirtazapine and sertraline versus placebo for the treatment of depression in d...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
King's College London (IOP)
Condition
Depression
Biological study icon
CompletedEUCTR 2014-005206-37

A Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a MonoAminergic antidepressant in Adults with Major Depressive Disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Poland
Why is this study shown?

This study is directly about Depression.

DepressionBiological
Countries
United Kingdom, Poland
Sponsor
Janssen-Cilag International N.V.
Condition
Depression
Drug study icon
CompletedEUCTR 2006-001196-38

A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) as Mono-Therapy in t...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Estonia
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Estonia, Finland
Sponsor
AstraZeneca AB
Condition
Depression
Drug study icon
CompletedEUCTR 2005-005053-22

A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) in Combination with ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Belgium, Czechia, Finland, ...
Sponsor
AstraZeneca AB
Condition
Depression
Drug study icon
CompletedEUCTR 2015-005282-22

A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Adaptive Dose-Finding Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
France, Bulgaria, Finland, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Drug study icon
CompletedEUCTR 2019-004440-29

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients with Major Depressive Episodes...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrug
Countries
Bulgaria
Sponsor
Intra-Cellular Therapies, Inc. (ITI)
Condition
Depression, Bipolarity
Drug study icon
CompletedEUCTR 2011-005200-15

A Phase IIa, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 for Treatment Augmentation in Patients with Major Depressive Disorder.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Finland, Germany, Norway, ...
Sponsor
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.